This report studies the Interventional Cardiology market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.
In the next five years, the global consumption of Interventional Cardiology will maintain more than 3% annual growth rate, Industry is mainly concentrated in Europe, USA, Japan and China.
At present, Chinese market is mainly occupied by imported brands. The domestic enterprise technology still needs to develop.
As Chinese number of heart disease and cardiovascular disease people is increasing, Chinese Interventional Cardiology market is predicted to be growing fast.
Average industry gross margin is between 70% and 80%, that is to say, Interventional Cardiology Project is a good investment choice. However, disadvantage factors and threat such as serious competition in Interventional Cardiology Industry should be considered.
The global Interventional Cardiology market was 3 million US$ in 2017 and is expected to 4 million US$ by the end of 2025, growing at a CAGR of 3.0% between 2018 and 2025.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Interventional Cardiology in these regions, from 2013 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Boston Scientific Corporation
BIOTRONIK SE & Co. KG
Bard Peripheral Vascular，Inc
OrbusNeich Medical, BV
Siemens Medical Solutions USA, Inc
By the product type, the market is primarily split into
Fractional flow reserve
By the end users/application, this report covers the following segments
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of Central & South America
Middle East & Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Interventional Cardiology market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Interventional Cardiology market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Interventional Cardiology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interventional Cardiology with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Interventional Cardiology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Interventional Cardiology are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Interventional Cardiology market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Raw material suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Interventional Cardiology market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.